+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Immunohistochemistry Market Size, Share & Trends Analysis Report by Product (Antibodies, Equipment, Reagents, Kits), by Application (Diagnostics, Drug Testing), by End Use, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4621739
  • Report
  • February 2020
  • Region: Global
  • 120 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abcam plc.
  • Bio SB
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Perkinelmer, Inc.
  • MORE
The global immunohistochemistry market size is expected to reach a value of USD 3.2 billion by 2027, expanding at a CAGR of 7.8%. Rising prevalence of chronic diseases, increasing regulatory approvals, and launch of technologically advanced immunohistochemistry (IHC) systems are expected to propel market growth over the forecast period.

IHC has become a crucial technique and is widely applied in the diagnosis of several chronic diseases such as cancer, infectious diseases, and cardiovascular diseases (CVDs). Thus, a rise in the incidence of these chronic diseases has led to an increase in the demand for IHC techniques. According to 2018 data published by WHO, globally, cancer was one of the leading causes of mortality, and in 2018 around 9.6 million deaths were registered due to cancer. The same source also states that every year CVDs cause around 17.9 million deaths, globally.

Furthermore, increasing regulatory approval and launch of novel IHC products are expected to support IHC market growth. For instance, in May 2019, F. Hoffmann-La Roche AG launched its new VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody, intended for the detection of ROS1-positive cancer cases. Additionally, in June 2019, the U.S. FDA approved the expanded use of Agilent Technologies’ PD-L1 IHC 22C3 pharmDx assay for the detection of head and neck squamous cell carcinoma (HNSCC). This product is used in patients receiving treatment with Merck and Co., Inc.’s Keytruda (Pembrolizumab).

However, various limitations associated with immunohistochemistry techniques and the high cost of automated IHC instruments are expected to hinder market growth over the forecast period. Automated immunohistochemistry instruments for disease diagnosis involve high setup costs. As a result, various emerging economies still rely on cost-effective traditional diagnostics that are based on immunostaining of thin tissue sections.

Further key findings from the study suggest:
  • Antibodies product segment held the largest market share in 2019 owing to increasing product approval and their high adoption rate, leading to a high demand for IHC techniques
  • The diagnostics application segment dominated the IHC market in 2019 and is expected to witness the highest growth over the forecast period due to the rising prevalence of chronic diseases
  • Hospitals and diagnostic laboratories dominated the market, by end use in 2019 owing to an increase in the number of hospitals and diagnostic centers with advanced infrastructure and the growing incidence of life-threatening diseases
  • North America held the largest market share in 2019 due to the presence of well-established healthcare infrastructure, favorable healthcare reimbursement policies, and the presence of major players in U.S.
  • Asia Pacific is anticipated to exhibit fastest growth over the forecast period due to the increasing prevalence of chronic diseases in countries such as China and India
  • Some of the key players of immunohistochemistry market are Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Agilent Technologies, Inc., and Abcam plc.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abcam plc.
  • Bio SB
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Perkinelmer, Inc.
  • MORE
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Immunohistochemistry (IHC) Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 High prevalence of chronic diseases
3.3.1.2 Intoduction of technologically advanced IHC solutions
3.3.1.3 Increasing R&D investments
3.3.1.4 Strategic initiatives by major players
3.3.1.5 Improving healthcare infrastructure in emerging economies
3.3.2 Market Restraint Analysis
3.3.2.1 High cost of IHC instruments
3.3.2.2 Limitations associated with IHC techniques
3.3.2.3 Increasing Product recalls
3.3.3 Industry challenges
3.3.3.1 Presence of ambiguous regulatory framework
3.4 Immunohistochemistry (IHC) Market Analysis Tools
3.4.1 Industry analysis – Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
3.4.3 Major deals and strategic alliances
3.4.3.1 Joint ventures
3.4.3.2 Mergers and acquisitions
3.4.3.3 Licensing and partnership
3.4.3.4 Technology collaborations
3.4.3.5 Strategic Divestments
3.4.4 Market entry strategies

Chapter 4 Immunohistochemistry (IHC) Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2019
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive dashboard analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis

Chapter 5 Immunohistochemistry (IHC) Market: Product Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Immunohistochemistry (IHC) Market, by Product, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.5.1 Antibodies
5.5.1.1 Antibodies Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.1.2 Primary Antibodies
5.5.1.2.1 Primary Antibodies Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.1.3 Secondary Antibodies
5.5.1.3.1 Secondary Antibodies Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2 Equipment
5.5.2.1 Equipment Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2.2 Slide Staining Systems
5.5.2.2.1 Slide Staining Systems Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2.3 Tissue Microarrays
5.5.2.3.1 Tissue Microarrays Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2.4 Tissue Processing Systems
5.5.2.4.1 Tissue Processing Systems Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2.5 Slide Scanners
5.5.2.5.1 Slide Scanners Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2.6 Others
5.5.2.6.1 Others Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3 Reagents
5.5.3.1 Reagents Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.2 Histological Stains
5.5.3.2.1 Histological Stains Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.3 Blocking Sera and Reagents
5.5.3.3.1 Blocking Sera and Reagents Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.4 Chromogenic Substrates
5.5.3.4.1 Chromogenic Substrates Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.5 Fixation Reagents
5.5.3.5.1 Fixation Reagents Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.6 Stabilizers
5.5.3.6.1 Stabilizers Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.7 Organic Solvents
5.5.3.7.1 Organic Solvents Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.8 Proteolytic Enzymes
5.5.3.8.1 Proteolytic Enzymes Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.9 Diluents
5.5.3.9.1 Diluents Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.4 Kits
5.5.4.1 Kits Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 6 Immunohistochemistry (IHC) Market: Application Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Technology Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 Global Immunohistochemistry (IHC) Market, by Application, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
6.5.1 Diagnostics
6.5.1.1 Diagnostics Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.1.2 Cancer
6.5.1.2.1 Cancer Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.1.3 Infectious Diseases
6.5.1.3.1 Infectious Diseases Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.1.4 Cardiovascular Diseases
6.5.1.4.1 Cardiovascular Diseases Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.1.5 Autoimmune Diseases
6.5.1.5.1 Autoimmune Diseases Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.1.6 Diabetes Mellitus
6.5.1.6.1 Diabetes Mellitus Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.1.7 Nephrological Diseases
6.5.1.7.1 Nephrological Diseases Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.2 Drug Testing
6.5.2.1 Drug Testing Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 7 Immunohistochemistry (IHC) Market: End Use Estimates And Trend Analysis
7.1 Definition & Scope
7.2 Testing Type Market Share Analysis, 2019 & 2027
7.3 Segment Dashboard
7.4 Global Immunohistochemistry (IHC) Market, by End Use, 2016 to 2027
7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
7.5.1 Hospitals & Diagnostic Laboratories
7.5.1.1 Hospitals & Diagnostic Laboratories Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.2 Research Institutes
7.5.2.1 Research Institutes Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.3 Others
7.5.3.1 Others Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 8 Immunohistochemistry (IHC) Market: Regional Estimates & Trend Analysis
8.1 Regional Market Snapshot
8.2 Regional Market Share and Leading Players, 2019
8.2.1 North America
8.2.2 Europe
8.2.3 Latin America
8.2.4 Asia Pacific
8.2.5 Middle East & Africa
8.3 Market Share Analysis by Country, 2019
8.3.1 North America
8.3.1.1 U.S.
8.3.1.2 Canada
8.3.2 Europe
8.3.2.1 U.K.
8.3.2.2 Germany
8.3.2.3 Spain
8.3.2.4 France
8.3.2.5 Italy
8.3.2.6 Russia
8.3.3 Latin America
8.3.3.1 Brazil
8.3.3.2 Mexico
8.3.3.3 Argentina
8.3.4 Asia Pacific
8.3.4.1 Japan
8.3.4.2 China
8.3.4.3 India
8.3.4.4 South Korea
8.3.4.5 Singapore
8.3.4.6 Australia
8.3.5 Middle East & Africa
8.3.5.1 South Africa
8.3.5.2 Saudi Arabia
8.3.5.3 UAE
8.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.4.1 North America
8.4.2 Europe
8.4.3 Latin America
8.4.4 Asia Pacific
8.4.5 Middle East & Africa
8.5 Market Size & Forecasts, and Trend Analysis, 2019 to 2027
8.5.1 North America
8.5.1.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
8.5.1.2 U.S.
8.5.1.2.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.1.2.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.1.2.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.1.3 Canada
8.5.1.3.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.1.3.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.1.3.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.2 Europe
8.5.2.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
8.5.2.2 U.K.
8.5.2.2.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.2.2.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.2.2.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.2.3 Germany
8.5.2.3.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.2.3.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.2.3.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.2.4 Spain
8.5.2.4.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.2.4.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.2.4.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.2.5 France
8.5.2.5.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.2.5.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.2.5.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.2.6 Italy
8.5.2.6.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.2.6.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.2.6.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.2.7 Russia
8.5.2.7.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.2.7.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.2.7.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.3 Latin America
8.5.3.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
8.5.3.2 Brazil
8.5.3.2.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.3.2.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.3.2.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.3.3 Mexico
8.5.3.3.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.3.3.2 MMarket Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.3.3.3 MMarket Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.3.4 Argentina
8.5.3.4.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.3.4.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.3.4.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.4 Asia Pacific
8.5.4.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
8.5.4.2 Japan
8.5.4.2.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.4.2.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.4.2.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.4.3 China
8.5.4.3.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.4.3.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.4.3.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.4.4 India
8.5.4.4.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.4.4.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.4.4.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.4.5 South Korea
8.5.4.5.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.4.5.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.4.5.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.4.6 Singapore
8.5.4.6.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.4.6.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.4.6.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.4.7 Australia
8.5.4.7.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.4.7.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.4.7.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.5 Middle East & Africa
8.5.5.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
8.5.5.2 South Africa
8.5.5.2.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.5.2.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.5.2.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.5.3 Saudi Arabia
8.5.5.3.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.5.3.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.5.3.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)
8.5.5.4 UAE
8.5.5.4.1 Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
8.5.5.4.2 Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
8.5.5.4.3 Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD million)

Chapter 9 Company Profiles
9.1 Company Profiles
9.1.1 Thermo Fisher Scientific, Inc.
9.1.1.1 Company overview
9.1.1.2 Financial Performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 F. Hoffmann-La Roche Ltd.
9.1.2.1 Company overview
9.1.2.2 Financial Performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Merck KGaA
9.1.3.1 Company overview
9.1.3.2 Financial Performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 Danaher Corporation
9.1.4.1 Company overview
9.1.4.2 Financial Performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 Perkinelmer, Inc.
9.1.5.1 Company overview
9.1.5.2 Financial Performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Bio-Rad Laboratories, Inc.
9.1.6.1 Company overview
9.1.6.2 Financial Performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 Cell Signaling Technology, Inc.
9.1.7.1 Company overview
9.1.7.2 Financial Performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Bio SB
9.1.8.1 Company overview
9.1.8.2 Financial Performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 Agilent Technologies, Inc.
9.1.9.1 Company overview
9.1.9.2 Financial Performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives
9.1.10 Abcam plc.
9.1.10.1 Company overview
9.1.10.2 Financial Performance
9.1.10.3 Product benchmarking
9.1.10.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Danaher Corporation
  • Perkinelmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Bio SB
  • Agilent Technologies, Inc.
  • Abcam plc.
Note: Product cover images may vary from those shown
Adroll
adroll